A novel malignant mesothelioma organoids-T cell co-culture platform for personalized immunochemotherapy testing

January 9, 2026 | Comments Off on A novel malignant mesothelioma organoids-T cell co-culture platform for personalized immunochemotherapy testing

Scientific Reports 2025 November 21 [Link] Yang Liu, Yang Yang, Songlin An, Hua Wan, Minghao Zhang, Ruihong Yin, Weiting Zhao, Li Huang, Yunshan Zhao, Chenggang Li Abstract Malignant mesothelioma (MM)…

Hyperthermic Intrathoracic Chemotherapy and Photodynamic Therapy: A Single-Institution Experience for Malignant Pleural Diseases

January 8, 2026 | Comments Off on Hyperthermic Intrathoracic Chemotherapy and Photodynamic Therapy: A Single-Institution Experience for Malignant Pleural Diseases

Oncology 2025 November 20 [Link] Yu-An Zheng, Ke-Cheng Chen, Pei-Ming Huang, Mong-Wei Lin, Shuenn-Wen Kuo, Jang-Ming Lee Abstract Introduction: Hyperthermic intrathoracic chemotherapy (HITHOC) is an intraoperative treatment that involves the…

Unraveling Peritoneal Mesothelioma: A Case-Based Discussion on Diagnosis and Management

January 7, 2026 | Comments Off on Unraveling Peritoneal Mesothelioma: A Case-Based Discussion on Diagnosis and Management

Cureus 2025 October 15 [Link] Othmane Zouiten, Latifa Azarou, Hasnaa Hadiri, Hanane Rais, Rhizlane Belbaraka Abstract Peritoneal mesothelioma is a rare and aggressive tumor, and its management remains poorly standardized…

Comprehensive analysis reveals prognostic gene set that could impacts the response to chemotherapy and immunotherapy outcomes in malignant pleural mesothelioma

January 6, 2026 | Comments Off on Comprehensive analysis reveals prognostic gene set that could impacts the response to chemotherapy and immunotherapy outcomes in malignant pleural mesothelioma

Clinical and Experimental Medicine 2025 November 18 [Link] Jun Li, Hongye He, Yutao Zhang, Muhammad Salman Azhar, Yongxiang Wang Abstract Malignant pleural mesothelioma (MPM) is a rare but aggressive thoracic…

Positron emission tomography/computed tomography in risk-factor-negative young female with malignant pleural mesothelioma: A case report and review of literature

January 5, 2026 | Comments Off on Positron emission tomography/computed tomography in risk-factor-negative young female with malignant pleural mesothelioma: A case report and review of literature

World Journal of Clinical Cases 2025 November 16 [Link] Aikedan Aisikaer, Mo-Mo Sun, Jie Shen Abstract Background: Malignant pleural mesothelioma (MPM), a rare aggressive malignancy, is primarily caused by asbestos…

Methylation biomarkers can distinguish pleural mesothelioma from healthy pleura and other pleural pathologies

December 19, 2025 | Comments Off on Methylation biomarkers can distinguish pleural mesothelioma from healthy pleura and other pleural pathologies

Molecular Oncology 2025 November 14 [Link] Janah Vandenhoeck, Nele De Meulenaere, Thomas Vanpoucke, Joe Ibrahim, Dieter Peeters, Suresh Krishan Yogeswaran, Wen Wen, Paul Van Schil, Jeroen M H Hendriks, Jo…

Neoadjuvant systemic therapy for pleural mesothelioma patients: a systematic review

December 18, 2025 | Comments Off on Neoadjuvant systemic therapy for pleural mesothelioma patients: a systematic review

Translational Lung Cancer Research 2025 October 31 [Link] Illaa Smesseim, Jo Raskin, Jacobus A Burgers Abstract Background: Pleural mesothelioma is an aggressive malignancy with a poor prognosis. The role of…

A Case of Primary Malignant Peritoneal Mesothelioma

December 17, 2025 | Comments Off on A Case of Primary Malignant Peritoneal Mesothelioma

Cureus 2025 October 5 [Link] Liz Betancourt, Jennifer Wallace, Eli Sugarman, Bryant Estevez, Nick La Roz, Evert Castillo, Rolando Torres, Damian Casadesus Abstract Primary malignant mesothelioma (MPM) is a rare…

Dynamic evolution of NK cells and immune remodeling mediated by CRS + HIPEC: prognostic mechanisms and therapeutic implications for malignant peritoneal mesothelioma

December 16, 2025 | Comments Off on Dynamic evolution of NK cells and immune remodeling mediated by CRS + HIPEC: prognostic mechanisms and therapeutic implications for malignant peritoneal mesothelioma

World Journal of Surgical Oncology 2025 November 3 [Link] Yi-Tong Liu, Qi-Di Zhao, Xin-Li Liang, Ru Ma, Yan-Dong Su, Rui Yang, Tian Wei, He-Liang Wu, Yu-Bin Fu, Yu-Run Cui, Yang…

Intratumour, anatomical and temporal heterogeneity in mesothelioma

December 15, 2025 | Comments Off on Intratumour, anatomical and temporal heterogeneity in mesothelioma

Thorax 2025 October 31 [Link] Maya Arnould, Mark D J Neilly, Kevin G Blyth, Didier Jean Abstract Background: Pleural mesothelioma (PM) is characterised by marked heterogeneity, both clinically in terms…

Categories